Revenue - Taro Pharmaceutical Industries Ltd (NYSE:TARO) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 42.4 USD -0.19%

Updated:

Taro Pharmaceutical Industries Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Taro Pharmaceutical Industries Ltd
Revenue Peer Comparison

T

TEVA

I

INCR

MDWD

R

REKA

C

CSURE

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Taro Pharmaceutical Industries Ltd NYSE:TARO	Revenue $610.8m	CAGR 3-Years 2%	CAGR 5-Years -2%	CAGR 10-Years -2%
T	Teva Pharmaceutical Industries Ltd TASE:TEVA	Revenue $15.8B	CAGR 3-Years -2%	CAGR 5-Years -3%	CAGR 10-Years -2%
I	InterCure Ltd TASE:INCR	Revenue ₪414.8m	CAGR 3-Years 164%	CAGR 5-Years N/A	CAGR 10-Years 48%
	Mediwound Ltd NASDAQ:MDWD	Revenue $18.7m	CAGR 3-Years -5%	CAGR 5-Years 41%	CAGR 10-Years N/A
R	Rekah Pharmaceutical Industry Ltd TASE:REKA	Revenue ₪315.3m	CAGR 3-Years 10%	CAGR 5-Years 9%	CAGR 10-Years 1%
C	Cannassure Therapeutics Ltd TASE:CSURE	Revenue ₪33.8m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Revenue amounts to 610.8m USD.

Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Taro Pharmaceutical Industries Ltd have been 2% over the past three years , -2% over the past five years , and -2% over the past ten years .

Join more than 132,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.